No Data
NRX Pharmaceuticals Analyst Ratings
Express News | NRX Pharmaceuticals Inc : Ascendiant Capital Markets Raises Target Price to $44 From $43
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
NRx Pharmaceuticals Reports Potential Acquisition and Financing Agreements